A bacterial ATP synthase binding domain

Details for Australian Patent Application No. 2012216368 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Andries, Koenraad Jozef Lodewijk Marcel; Gohlmann, Hinrich Wilhelm Helmut; Neefs, Jean-Marc Edmond Fernand Marie; Verhasselt, Peter Karcel Maria; Winkler, Johann; de Jonge, Marc Rene; Koymans, Lucien Maria Henricus

Agent Shelston IP

Pub. Number AU-A-2012216368

Parent 2005288848

Filing date 16 August 2012

Wipo publication date 13 September 2012

International Classifications

C07K 14/35 Peptides having more than 20 amino acids

A61K 31/00

C12N 15/31 Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12N 15/52 Mutation or genetic engineering - Genes encoding for enzymes or proenzymes

G01N 33/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

6 September 2012 Complete Application Filed

13 September 2012 Application Open to Public Inspection

  Published as AU-A-2012216368

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012216369-Power conversion system and method

2012216367-Emergency disconnect sequence video sharing